tiprankstipranks
Bright Minds Biosciences Inc. (DRUG)
:DRUG
US Market

Bright Minds Biosciences (DRUG) Income Statement

Compare
215 Followers

Bright Minds Biosciences Income Statement

Last quarter (Q1 2025), Bright Minds Biosciences's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Bright Minds Biosciences's net income was C$49.61K. See Bright Minds Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -72.45KC$ -6.04KC$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 7.29MC$ 14.73MC$ 8.60MC$ 469.36KC$ 78.72K
Depreciation and Amortization
C$ 72.45KC$ 6.04KC$ 8.62MC$ 474.93KC$ 236.15K
EBITDA
C$ -7.28MC$ -14.96MC$ 0.00C$ 0.00C$ 0.00
Operating Income
C$ -7.37MC$ -14.74MC$ -8.76MC$ -469.36KC$ -78.72K
Other Income/Expenses
C$ -5.56KC$ -232.93KC$ -27.64KC$ -5.45KC$ 157.43K
Pretax Income
C$ -7.37MC$ -14.96MC$ -8.65MC$ -480.38KC$ -78.72K
Net Income
C$ -7.37MC$ -15.19MC$ -8.52MC$ -485.94KC$ -78.72K
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -1.98C$ -6.15C$ -4.74C$ -0.38C$ -0.06
Diluted EPS
C$ -1.98C$ -6.15C$ -4.74C$ -0.38C$ -0.06
Weighted Average Shares Outstanding
3.72M 2.47M 1.79M 1.28M 1.28M
Weighted Average Shares Outstanding (Diluted)
3.72M 2.47M 1.79M 1.28M 1.28M
Currency in CAD

Bright Minds Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis